Skip to main content
Premium Trial:

Request an Annual Quote

Sygnis Grosses €5.3M in Rights Offering, Private Placement

NEW YORK (GenomeWeb) – German molecular biology tools firm Sygnis announced yesterday that it has raised roughly €5.3 million ($5.9 million) in gross proceeds through a rights offering and subsequent private stock placement.

The funds, the company said, will be used for expenses associated with its planned €1.7 million cash-and-stock acquisition of UK-based proteomics reagents company Expedeon, as well as for one-time integration costs and working capital.

According to Sygnis, it sold roughly 4.8 million shares, including 3 million newly issued shares to existing investors and 1.8 million placed at a subscription price of €1.10 with qualified investors in a rump placement. An additional 15.7 million shares will be offered to Expedeon shareholders against contribution in kind.

Sygnis said that following the transactions, its share capital will increase to €37,341,980.

The Scan

Foxtail Millet Pangenome, Graph-Based Reference Genome

Researchers in Nature Genetics described their generation of a foxtail millet pangenome, which they say can help in crop trait improvement.

Protein Length Distribution Consistent Across Species

An analysis in Genome Biology compares the lengths of proteins across more than 2,300 species, finding similar length distributions.

Novel Genetic Loci Linked to Insulin Resistance in New Study

A team reports in Nature Genetics that it used glucose challenge test data to home in on candidate genes involved in GLUT4 expression or trafficking.

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.